AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇿🇼

ENALAPRIL MALEATE in Zimbabwe

9 products registered with MCAZ 9 active

Brand / ProductReg. No.HolderStatusExpires
VIACE
TABLET; ORAL
2019/12.3.5/5771VARICHEM PHARMACEUTICALS (PVT) LTDactive17 Sept 2030
VIACE
TABLET; ORAL
2019/12.3.5/5838VARICHEM PHARMACEUTICALS (PVT) LTDactive17 Sept 2030
ENVAS-10
TABLET; ORAL
2001/12.3.1/3962CADILA PHARMACEUTICALS LTDactive11 Apr 2030
ENAPRIL 10
TABLET; ORAL
2020/12.3.5/5954INTAS PHARMACEUTICAL LIMITEDactive18 Jul 2029
ENAPRIL 5
TABLET; ORAL
2020/12.3.5/5953INTAS PHARMACEUTICALS LTDactive18 Jul 2029
RENNIMED 20
TABLET; ORAL
2005/12.3.5/4401PLUS FIVE PHARMACEUTICALS PVT LTDactive31 Dec 2027
KORANDIL 10
TABLET; ORAL
99/12.3.5/3599REMEDICA LTDactive31 Dec 2027
RENNIMED 10
TABLET; ORAL
2005/12.3.5/4400PLUS FIVE PHARMACEUTICALS PVT LTDactive31 Dec 2027
KORANDIL 20
TABLET; ORAL
99/12.3.5/3600REMEDICA LTDactive31 Dec 2027

ENALAPRIL MALEATEMCAZ Registration Details

MCAZ (Zimbabwe) has 9 registered products containing ENALAPRIL MALEATE, of which 9 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track ENALAPRIL MALEATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.